本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Cidara Therapeutics, Inc.

217.83
+0.11500.05%
成交量:201.58萬
成交額:4.39億
市值:68.48億
市盈率:-21.33
高:218.17
開:217.50
低:217.41
收:217.71
52周最高:218.85
52周最低:13.90
股本:3,143.94萬
流通股本:2,486.62萬
量比:2.81
換手率:8.11%
股息:- -
股息率:- -
每股收益(TTM):-10.2103
每股收益(LYR):-26.7460
淨資產收益率:-68.70%
總資產收益率:-29.35%
市淨率:16.21
市盈率(LYR):-8.14

資料載入中...

2024/12/30

SEC問詢函

Form CORRESP - Correspondence
2024/12/23

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/12/09

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/12/05

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/12/04

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/26

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/26

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

重要事件披露

Form 8-K - Current report
2024/11/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/09/23

重要事件披露

Form 8-K - Current report
2024/09/12

重要事件披露

Form 8-K - Current report
2024/08/13

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

重要事件披露

Form 8-K - Current report
2024/07/30

SEC問詢函

Form CORRESP - Correspondence
2024/07/29

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/07/29

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/07/26

超過5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/07/19

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933